Haemolytic uraemic syndrome
Top Cited Papers
- 1 August 2017
- journal article
- review article
- Published by Elsevier BV in The Lancet
- Vol. 390 (10095), 681-696
- https://doi.org/10.1016/s0140-6736(17)30062-4
Abstract
No abstract availableKeywords
This publication has 153 references indexed in Scilit:
- Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic SyndromeNew England Journal of Medicine, 2013
- Recessive mutations in DGKE cause atypical hemolytic-uremic syndromeNature Genetics, 2013
- Strategies for Surveillance of Pediatric Hemolytic Uremic Syndrome: Foodborne Diseases Active Surveillance Network (FoodNet), 2000-2007Clinical Infectious Diseases, 2012
- Immunoadsorption in patients with haemolytic uraemic syndrome – Authors' replyThe Lancet, 2012
- Immunoadsorption in patients with haemolytic uraemic syndromeThe Lancet, 2012
- Antibiotic Treatment of Escherichia coli O157 Infection and the Risk of Hemolytic Uremic Syndrome, MinnesotaThe Pediatric Infectious Disease Journal, 2012
- Thrombomodulin Mutations in Atypical Hemolytic–Uremic SyndromeNew England Journal of Medicine, 2009
- VEGF Inhibition and Renal Thrombotic MicroangiopathyNew England Journal of Medicine, 2008
- Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndromeProceedings of the National Academy of Sciences of the United States of America, 2007
- Cobalamin C defect associated with hemolytic-uremic syndromeThe Journal of Pediatrics, 1992